全文获取类型
收费全文 | 121394篇 |
免费 | 10198篇 |
国内免费 | 406篇 |
专业分类
耳鼻咽喉 | 1284篇 |
儿科学 | 3204篇 |
妇产科学 | 2437篇 |
基础医学 | 17166篇 |
口腔科学 | 2736篇 |
临床医学 | 12781篇 |
内科学 | 25761篇 |
皮肤病学 | 2096篇 |
神经病学 | 12343篇 |
特种医学 | 4917篇 |
外国民族医学 | 6篇 |
外科学 | 17059篇 |
综合类 | 1687篇 |
一般理论 | 106篇 |
预防医学 | 9944篇 |
眼科学 | 2041篇 |
药学 | 8789篇 |
中国医学 | 121篇 |
肿瘤学 | 7520篇 |
出版年
2023年 | 609篇 |
2021年 | 2129篇 |
2020年 | 1498篇 |
2019年 | 2287篇 |
2018年 | 2772篇 |
2017年 | 2060篇 |
2016年 | 2416篇 |
2015年 | 2788篇 |
2014年 | 3720篇 |
2013年 | 4901篇 |
2012年 | 7559篇 |
2011年 | 7649篇 |
2010年 | 4454篇 |
2009年 | 4077篇 |
2008年 | 6730篇 |
2007年 | 7383篇 |
2006年 | 6843篇 |
2005年 | 6785篇 |
2004年 | 6378篇 |
2003年 | 5707篇 |
2002年 | 5641篇 |
2001年 | 2572篇 |
2000年 | 2549篇 |
1999年 | 2242篇 |
1998年 | 1277篇 |
1997年 | 1054篇 |
1996年 | 870篇 |
1995年 | 1042篇 |
1994年 | 886篇 |
1993年 | 824篇 |
1992年 | 1664篇 |
1991年 | 1603篇 |
1990年 | 1518篇 |
1989年 | 1479篇 |
1988年 | 1327篇 |
1987年 | 1287篇 |
1986年 | 1266篇 |
1985年 | 1231篇 |
1984年 | 1013篇 |
1983年 | 861篇 |
1982年 | 776篇 |
1981年 | 635篇 |
1980年 | 552篇 |
1979年 | 797篇 |
1978年 | 672篇 |
1977年 | 555篇 |
1975年 | 517篇 |
1974年 | 563篇 |
1973年 | 517篇 |
1972年 | 508篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
Härter Martin Koch-Gromus Uwe 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(3):267-269
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - 相似文献
2.
Jana Kristin Eckert Julia Kahle Andreas Bck Kathrin Zeber Kathrin Urner Wolfgang Greiner Simone Kreimeier Kirsten Beyer Josefine Dobbertin-Welsch Eckard Hamelmann Ines Gellhaus Christina Schorlemer Michael Kabesch Parastoo Kheiroddin Erika von Mutius Martin Depner Daniel Walter Gesine Hansen Stephanie DeStefano Sabine Schnadt Bianca Schaub 《Pediatric allergy and immunology》2022,33(1):e13652
3.
4.
5.
Andreas Lundin Martin Annborn Ola Borgquist Joachim Düring Johan Undén Christian Rylander 《Acta anaesthesiologica Scandinavica》2023,67(5):655-662
Patients admitted to intensive care after cardiac arrest are at risk of circulatory shock and early mortality due to cardiovascular failure. The aim of this study was to evaluate the ability of the veno-arterial pCO2 difference (∆pCO2; central venous CO2 – arterial CO2) and lactate to predict early mortality in postcardiac arrest patients. This was a pre-planned prospective observational sub-study of the target temperature management 2 trial. The sub-study patients were included at five Swedish sites. Repeated measurements of ∆pCO2 and lactate were conducted at 4, 8, 12, 16, 24, 48, and 72 h after randomization. We assessed the association between each marker and 96-h mortality and their prognostic value for 96-h mortality. One hundred sixty-three patients were included in the analysis. Mortality at 96 h was 17%. During the initial 24 h, there was no difference in ∆pCO2 levels between 96-h survivors and non-survivors. ∆pCO2 measured at 4 h was associated with an increased risk of death within 96 h (adjusted odds ratio: 1.15; 95% confidence interval [CI]: 1.02–1.29; p = .018). Lactate levels were associated with poor outcome over multiple measurements. The area under the receiving operating curve to predict death within 96 h was 0.59 (95% CI: 0.48–0.74) and 0.82 (95% CI: 0.72–0.92) for ∆pCO2 and lactate, respectively. Our results do not support the use of ∆pCO2 to identify patients with early mortality in the postresuscitation phase. In contrast, non-survivors demonstrated higher lactate levels in the initial phase and lactate identified patients with early mortality with moderate accuracy. 相似文献
6.
7.
8.
Steven P. Rowe MD PhD Martin G. Pomper MD PhD 《CA: a cancer journal for clinicians》2022,72(4):333-352
The authors define molecular imaging, according to the Society of Nuclear Medicine and Molecular Imaging, as the visualization, characterization, and measurement of biological processes at the molecular and cellular levels in humans and other living systems. Although practiced for many years clinically in nuclear medicine, expansion to other imaging modalities began roughly 25 years ago and has accelerated since. That acceleration derives from the continual appearance of new and highly relevant animal models of human disease, increasingly sensitive imaging devices, high-throughput methods to discover and optimize affinity agents to key cellular targets, new ways to manipulate genetic material, and expanded use of cloud computing. Greater interest by scientists in allied fields, such as chemistry, biomedical engineering, and immunology, as well as increased attention by the pharmaceutical industry, have likewise contributed to the boom in activity in recent years. Whereas researchers and clinicians have applied molecular imaging to a variety of physiologic processes and disease states, here, the authors focus on oncology, arguably where it has made its greatest impact. The main purpose of imaging in oncology is early detection to enable interception if not prevention of full-blown disease, such as the appearance of metastases. Because biochemical changes occur before changes in anatomy, molecular imaging—particularly when combined with liquid biopsy for screening purposes—promises especially early localization of disease for optimum management. Here, the authors introduce the ways and indications in which molecular imaging can be undertaken, the tools used and under development, and near-term challenges and opportunities in oncology. 相似文献
9.
The use of radiation for primary liver cancers has historically been limited because of the risk of radiation-induced liver disease. Treatment fields have become more conformal because of several technical advances, and this has allowed for dose escalation. Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy, is now able to safely treat liver tumors to ablative doses while sparing functional liver parenchyma by using highly conformal therapy. Several retrospective and small prospective studies have examined the use of SBRT for liver cancers; however, there is a lack of well-powered randomized studies to definitively guide management in these settings. Recent advances in systemic therapy for primary liver cancers have improved outcomes; however, the optimal selection criteria for SBRT as a local therapy remain unclear among other liver-directed options such as radiofrequency ablation, transarterial chemoembolization, and radioembolization. 相似文献
10.
Tobias Hüppe Sascha Kreuer Hinnerk Wulf Dennik Freitag Martin Seidel Tobias Teucke Felix Maurer Andreas Kirschbaum Tilo Koch Frank Langer Thomas Volk Carsten Feldmann 《Acta anaesthesiologica Scandinavica》2023,67(4):455-461